Pharmaceutical Science Update

Posted By Linda Brown
Found In Microsite: AAPS News Magazine
August 15, 2018 Drugmakers could opt to use one clinical trial to study certain cancer drugs in humans rather than the three separate trials traditionally needed, thanks to the Food and Drug Administration’s (FDA) latest push to streamline drug approvals. ...
Posted By Linda Brown
Found In Microsite: AAPS News Magazine
August 15, 2018 New cancer therapies could reach patients more quickly under a proposal by two cancer groups to increase access to the clinical trials that are essential for Food and Drug Administration (FDA) approval. The proposal, which the groups ...
Posted By Linda Brown
Found In Microsite: AAPS News Magazine
August 15, 2018 Drugmakers have more avenues to prove their products treat opioid addiction now that the Food and Drug Administration (FDA) has expanded what types of outcomes it considers successful. FDA wants drugmakers to consider testing whether ...
Posted By Linda Brown
Found In Microsite: AAPS News Magazine
August 15, 2018 The Department of Health and Human Services’ (HHS) decision to extend legal protection to developers and distributors of potential Zika virus vaccines renews questions over whether the law allowing immunity goes too far. HHS extended ...
Posted By Linda Brown
Found In Microsite: AAPS News Magazine
August 8, 2018 The Food and Drug Administration (FDA) would get $2.97 billion in fiscal year 2019 discretionary funding in a “minibus” appropriations bill the Senate passed on Aug. 1, about $159 million over the current year’s enacted funding level. ...